IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Cilostazol

Drug Profile, Volume 02 Issue 2 – April to June 2009

Authors

Dr. R C Sreekumar, Consultant General and Vascular Surgeon, Medical College Hospital, Trivandrum; Secretary, IMA Trivandrum


Abstract

Cilostazol is used in patients with Peripheral occlusive vascular disease having the discomforting symptom of intermittent claudication. It acts by inhibiting cAMP phospho diesterase III inhibition. It inhibits platelet aggregation and has a direct vasodilatory action. Side effects include headache.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician